Kanglaite Injection combined with Gemzar (KG) versus Gemzar alone (G) in treating local advanced and metastatic pancreatic cancer: a multicenter randomized control clinical study.

Trial Profile

Kanglaite Injection combined with Gemzar (KG) versus Gemzar alone (G) in treating local advanced and metastatic pancreatic cancer: a multicenter randomized control clinical study.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Gemcitabine; Kanglaite
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
    • 14 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top